Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromans | 6 | 2019 | 59 | 1.410 |
Why?
|
| Thiones | 6 | 2019 | 55 | 1.410 |
Why?
|
| Antineoplastic Agents | 10 | 2019 | 686 | 0.900 |
Why?
|
| beta-Cyclodextrins | 1 | 2022 | 9 | 0.780 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 15 | 2007 | 52 | 0.770 |
Why?
|
| Triticum | 1 | 2022 | 13 | 0.770 |
Why?
|
| Anti-Arrhythmia Agents | 15 | 2007 | 117 | 0.740 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 8 | 2020 | 29 | 0.660 |
Why?
|
| Bacillus anthracis | 7 | 2015 | 153 | 0.620 |
Why?
|
| Folic Acid Antagonists | 6 | 2014 | 17 | 0.610 |
Why?
|
| Retinoids | 9 | 2004 | 38 | 0.550 |
Why?
|
| Thiourea | 6 | 2019 | 17 | 0.530 |
Why?
|
| Ovarian Neoplasms | 6 | 2019 | 607 | 0.480 |
Why?
|
| Pyrimidines | 5 | 2015 | 128 | 0.480 |
Why?
|
| HSP70 Heat-Shock Proteins | 2 | 2018 | 45 | 0.440 |
Why?
|
| Imidazoles | 6 | 2007 | 63 | 0.420 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2013 | 8 | 0.420 |
Why?
|
| Microspheres | 1 | 2013 | 49 | 0.400 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 104 | 0.400 |
Why?
|
| Structure-Activity Relationship | 14 | 2020 | 209 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 6 | 2015 | 536 | 0.360 |
Why?
|
| Staphylococcus aureus | 4 | 2020 | 121 | 0.340 |
Why?
|
| Enzyme Inhibitors | 3 | 2020 | 251 | 0.320 |
Why?
|
| Receptors, Retinoic Acid | 5 | 2005 | 32 | 0.290 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 1350 | 0.290 |
Why?
|
| Myocardial Ischemia | 2 | 2007 | 73 | 0.280 |
Why?
|
| Sotalol | 1 | 2007 | 9 | 0.270 |
Why?
|
| Drug Design | 2 | 2020 | 63 | 0.250 |
Why?
|
| Phenylurea Compounds | 1 | 2005 | 17 | 0.240 |
Why?
|
| Molecular Structure | 7 | 2015 | 245 | 0.230 |
Why?
|
| Phthalazines | 2 | 2015 | 25 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2015 | 612 | 0.210 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2020 | 149 | 0.210 |
Why?
|
| Bridged Bicyclo Compounds | 8 | 1995 | 21 | 0.210 |
Why?
|
| Models, Molecular | 9 | 2015 | 452 | 0.170 |
Why?
|
| Cell Proliferation | 3 | 2019 | 824 | 0.170 |
Why?
|
| Molecular Docking Simulation | 3 | 2018 | 53 | 0.160 |
Why?
|
| Drug Screening Assays, Antitumor | 4 | 2015 | 103 | 0.150 |
Why?
|
| Bacterial Proteins | 2 | 2012 | 497 | 0.140 |
Why?
|
| Animals | 23 | 2009 | 10684 | 0.130 |
Why?
|
| Dogs | 10 | 2007 | 510 | 0.120 |
Why?
|
| Trimethoprim | 2 | 2020 | 6 | 0.120 |
Why?
|
| Apoptosis | 5 | 2009 | 780 | 0.120 |
Why?
|
| Palladium | 1 | 2015 | 9 | 0.120 |
Why?
|
| Coenzymes | 1 | 2014 | 9 | 0.110 |
Why?
|
| Humans | 12 | 2019 | 28851 | 0.110 |
Why?
|
| Magnetic Phenomena | 1 | 2013 | 7 | 0.100 |
Why?
|
| Src Homology 2 Domain-Containing, Transforming Protein 1 | 1 | 2013 | 10 | 0.100 |
Why?
|
| Electrophysiology | 7 | 2007 | 150 | 0.100 |
Why?
|
| Tachycardia, Ventricular | 3 | 2007 | 60 | 0.100 |
Why?
|
| Heart | 5 | 1997 | 232 | 0.100 |
Why?
|
| Enterococcus faecalis | 1 | 2014 | 71 | 0.100 |
Why?
|
| Female | 10 | 2019 | 15624 | 0.100 |
Why?
|
| Benzoates | 2 | 2004 | 30 | 0.100 |
Why?
|
| Bile Ducts | 1 | 1991 | 6 | 0.090 |
Why?
|
| Urea | 2 | 2018 | 16 | 0.090 |
Why?
|
| Catheterization | 1 | 1991 | 50 | 0.090 |
Why?
|
| Phenotype | 2 | 2012 | 685 | 0.090 |
Why?
|
| Action Potentials | 4 | 2007 | 196 | 0.080 |
Why?
|
| Heart Conduction System | 2 | 2007 | 270 | 0.080 |
Why?
|
| Retinoid X Receptors | 3 | 2005 | 24 | 0.080 |
Why?
|
| Benzopyrans | 2 | 2004 | 22 | 0.080 |
Why?
|
| Mice | 7 | 2009 | 4802 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2009 | 275 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 103 | 0.070 |
Why?
|
| Protein Binding | 4 | 2014 | 667 | 0.070 |
Why?
|
| Ligation | 1 | 2007 | 39 | 0.070 |
Why?
|
| Pericardium | 1 | 2007 | 47 | 0.070 |
Why?
|
| Cell Division | 4 | 2004 | 154 | 0.070 |
Why?
|
| Male | 11 | 2009 | 13921 | 0.070 |
Why?
|
| Binding Sites | 2 | 2020 | 355 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2007 | 154 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 4 | 2001 | 314 | 0.060 |
Why?
|
| Skin Irritancy Tests | 1 | 2005 | 4 | 0.060 |
Why?
|
| Alanine Transaminase | 1 | 2005 | 27 | 0.060 |
Why?
|
| Fish Diseases | 2 | 1995 | 4 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 61 | 0.060 |
Why?
|
| Lidocaine | 3 | 1996 | 27 | 0.060 |
Why?
|
| Crystallography, X-Ray | 3 | 2015 | 222 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2005 | 472 | 0.060 |
Why?
|
| RNA | 1 | 2005 | 111 | 0.060 |
Why?
|
| Mycobacterium bovis | 1 | 2004 | 3 | 0.050 |
Why?
|
| X-Ray Diffraction | 2 | 2009 | 41 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2005 | 427 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2005 | 304 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 292 | 0.050 |
Why?
|
| Anthrax | 2 | 2012 | 91 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 1997 | 180 | 0.040 |
Why?
|
| Rats | 4 | 2009 | 1588 | 0.040 |
Why?
|
| Carcinoma | 1 | 2001 | 74 | 0.040 |
Why?
|
| Protein Structure, Secondary | 2 | 2010 | 130 | 0.040 |
Why?
|
| Benzamides | 1 | 1999 | 39 | 0.040 |
Why?
|
| Quinolines | 1 | 1999 | 35 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 1997 | 196 | 0.040 |
Why?
|
| Transcription Factors | 2 | 1999 | 523 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 1995 | 131 | 0.040 |
Why?
|
| Sulfur | 1 | 2018 | 35 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 1999 | 93 | 0.040 |
Why?
|
| Water Pollutants, Chemical | 2 | 1995 | 55 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1999 | 165 | 0.030 |
Why?
|
| Molecular Conformation | 2 | 2014 | 67 | 0.030 |
Why?
|
| Oxygen | 1 | 2018 | 237 | 0.030 |
Why?
|
| Cell Line | 1 | 1998 | 700 | 0.030 |
Why?
|
| Myocardial Infarction | 3 | 1996 | 351 | 0.030 |
Why?
|
| Myocardial Contraction | 2 | 1995 | 62 | 0.030 |
Why?
|
| Stereoisomerism | 2 | 2012 | 45 | 0.030 |
Why?
|
| Industrial Waste | 1 | 1995 | 7 | 0.030 |
Why?
|
| Soil Pollutants | 1 | 1995 | 17 | 0.030 |
Why?
|
| Hydrocarbons | 1 | 1995 | 41 | 0.030 |
Why?
|
| Fishes | 1 | 1995 | 32 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 133 | 0.030 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1994 | 9 | 0.030 |
Why?
|
| Sarcoplasmic Reticulum | 1 | 1994 | 7 | 0.030 |
Why?
|
| Electron Transport | 1 | 1994 | 31 | 0.030 |
Why?
|
| Mitochondria, Heart | 1 | 1994 | 26 | 0.030 |
Why?
|
| Myocardium | 2 | 1992 | 196 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2009 | 332 | 0.030 |
Why?
|
| Leucovorin | 1 | 2014 | 19 | 0.030 |
Why?
|
| NADP | 1 | 2014 | 39 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2014 | 112 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 151 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2014 | 267 | 0.030 |
Why?
|
| Ca(2+) Mg(2+)-ATPase | 1 | 1992 | 3 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 1992 | 10 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1994 | 255 | 0.020 |
Why?
|
| Chemistry Techniques, Synthetic | 1 | 2012 | 10 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 697 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 58 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 65 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1056 | 0.020 |
Why?
|
| Bile | 1 | 1991 | 4 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2012 | 126 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 63 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1993 | 168 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2012 | 258 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 2012 | 87 | 0.020 |
Why?
|
| Pressure | 1 | 1991 | 90 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2010 | 34 | 0.020 |
Why?
|
| Lethal Dose 50 | 2 | 2000 | 14 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 284 | 0.020 |
Why?
|
| Rabbits | 3 | 1995 | 277 | 0.020 |
Why?
|
| In Vitro Techniques | 3 | 1995 | 242 | 0.020 |
Why?
|
| Mutagenicity Tests | 1 | 2009 | 4 | 0.020 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2009 | 8 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2009 | 58 | 0.020 |
Why?
|
| Body Weight | 2 | 2000 | 250 | 0.020 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 22 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2009 | 38 | 0.020 |
Why?
|
| Glutathione | 1 | 2009 | 76 | 0.020 |
Why?
|
| Heart Rate | 3 | 1996 | 382 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2009 | 163 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2009 | 191 | 0.020 |
Why?
|
| Neoplasms | 1 | 1995 | 874 | 0.010 |
Why?
|
| Purkinje Fibers | 2 | 1997 | 37 | 0.010 |
Why?
|
| Blood Pressure | 2 | 1996 | 357 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 1995 | 54 | 0.010 |
Why?
|
| Guinea Pigs | 2 | 1995 | 73 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1995 | 554 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 1995 | 380 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2004 | 232 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2009 | 1469 | 0.010 |
Why?
|
| Indicators and Reagents | 2 | 1993 | 26 | 0.010 |
Why?
|
| Electric Stimulation | 2 | 1993 | 256 | 0.010 |
Why?
|
| Fenretinide | 1 | 2001 | 4 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2001 | 23 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2001 | 43 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 82 | 0.010 |
Why?
|
| Mucin-1 | 1 | 2001 | 36 | 0.010 |
Why?
|
| Drinking Behavior | 1 | 2000 | 6 | 0.010 |
Why?
|
| Drinking | 1 | 2000 | 8 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 2000 | 15 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 2000 | 17 | 0.010 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 1999 | 5 | 0.010 |
Why?
|
| Organ Size | 1 | 2000 | 88 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 26 | 0.010 |
Why?
|
| Transglutaminases | 1 | 1999 | 8 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1999 | 90 | 0.010 |
Why?
|
| Eating | 1 | 2000 | 71 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2000 | 104 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1999 | 86 | 0.010 |
Why?
|
| Ligands | 1 | 1999 | 178 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2000 | 173 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 404 | 0.010 |
Why?
|
| Diet | 1 | 2000 | 241 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2001 | 415 | 0.010 |
Why?
|
| Liver | 1 | 2000 | 471 | 0.010 |
Why?
|
| Ictaluridae | 1 | 1995 | 3 | 0.010 |
Why?
|
| Time Factors | 1 | 2000 | 1613 | 0.010 |
Why?
|
| Pigmentation | 1 | 1995 | 6 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1995 | 6 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1995 | 29 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1995 | 18 | 0.010 |
Why?
|
| Half-Life | 1 | 1995 | 34 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1995 | 94 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1995 | 66 | 0.010 |
Why?
|
| Biotransformation | 1 | 1995 | 9 | 0.010 |
Why?
|
| Biological Availability | 1 | 1995 | 44 | 0.010 |
Why?
|
| Petroleum | 1 | 1995 | 34 | 0.010 |
Why?
|
| Geologic Sediments | 1 | 1995 | 68 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1995 | 11 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 1995 | 69 | 0.010 |
Why?
|
| Fresh Water | 1 | 1995 | 63 | 0.010 |
Why?
|
| Submitochondrial Particles | 1 | 1994 | 2 | 0.010 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 1994 | 8 | 0.010 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1994 | 11 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 1994 | 29 | 0.010 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 1994 | 40 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 1994 | 50 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1995 | 398 | 0.010 |
Why?
|
| Ouabain | 1 | 1992 | 8 | 0.010 |
Why?
|
| Cyclopropanes | 1 | 1992 | 4 | 0.010 |
Why?
|
| Microelectrodes | 1 | 1991 | 19 | 0.010 |
Why?
|
| Ventricular Function | 1 | 1991 | 25 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1993 | 221 | 0.010 |
Why?
|
| Oklahoma | 1 | 1995 | 1052 | 0.010 |
Why?
|
| Ornithine Decarboxylase | 1 | 1991 | 9 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1991 | 31 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1991 | 139 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 1991 | 115 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1994 | 485 | 0.010 |
Why?
|
| Kinetics | 1 | 1991 | 553 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1992 | 787 | 0.010 |
Why?
|
| Skin | 1 | 1991 | 152 | 0.000 |
Why?
|